Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?
- Supplementary File 1:
PDF-Document (PDF, 296 KiB)
Hecel, A.; Ostrowska, M.; Stokowa-Sołtys, K.; Wątły, J.; Dudek, D.; Miller, A.; Potocki, S.; Matera-Witkiewicz, A.; Dominguez-Martin, A.; Kozłowski, H.; Rowińska-Żyrek, M. Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19? Pharmaceuticals 2020, 13, 228. https://doi.org/10.3390/ph13090228
Hecel A, Ostrowska M, Stokowa-Sołtys K, Wątły J, Dudek D, Miller A, Potocki S, Matera-Witkiewicz A, Dominguez-Martin A, Kozłowski H, Rowińska-Żyrek M. Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19? Pharmaceuticals. 2020; 13(9):228. https://doi.org/10.3390/ph13090228
Chicago/Turabian StyleHecel, Aleksandra, Małgorzata Ostrowska, Kamila Stokowa-Sołtys, Joanna Wątły, Dorota Dudek, Adriana Miller, Sławomir Potocki, Agnieszka Matera-Witkiewicz, Alicia Dominguez-Martin, Henryk Kozłowski, and Magdalena Rowińska-Żyrek. 2020. "Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?" Pharmaceuticals 13, no. 9: 228. https://doi.org/10.3390/ph13090228


